Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine and antianxiety activity.

D P Taylor, L A Riblet, H C Stanton

    Pharmacology, Biochemistry, and Behavior
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Translating Dental, Oral, and Craniofacial Regenerative Medicine Innovations to the Clinic through Interdisciplinary Commercial Translation Architecture.

    Journal of dental research·2021
    Same author

    Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.

    Australian veterinary journal·2017
    Same author

    Chemotherapy for dogs with lymph node metastasis from histiocytic sarcomas.

    Australian veterinary journal·2017
    Same author

    Piroxicam and doxycycline treatment for an oral squamous cell carcinoma in an inshore bottlenose dolphin (Tursiops aduncus).

    Australian veterinary journal·2016
    Same author

    Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system.

    British journal of cancer·2014
    Same author

    Sexual Attraction and Mating Patterns in Cylindrocorpus longistoma and C. curzii (Nematoda: Cylindrocorporidae).

    Journal of nematology·2009
    Same journal

    Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol.

    Pharmacology, biochemistry, and behavior·2026
    Same journal

    Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease.

    Pharmacology, biochemistry, and behavior·2026
    See all related articles

    Buspirone effectively treats anxiety without affecting the benzodiazepine/gamma-aminobutyric acid (GABA) axis, unlike traditional drugs. This anxioselective agent interacts with the dopaminergic system, suggesting dopamine

    Area of Science:

    • Neuropharmacology
    • Anxiolytic Drug Research
    • Dopamine System Studies

    Background:

    • Buspirone is an effective anxiolytic comparable to diazepam.
    • Unlike benzodiazepines, buspirone does not interact with the benzodiazepine/gamma-aminobutyric acid (GABA) axis.
    • Buspirone is classified as an anxioselective agent due to its unique mechanism.

    Purpose of the Study:

    • To investigate the neuropharmacological basis of buspirone's anxiolytic effects.
    • To explore the role of the dopaminergic system in anxiety and its treatment.
    • To review the efficacy of non-benzodiazepine drugs, particularly dopaminergic agents, in anxiety management.

    Main Methods:

    • Review of clinical trial data on buspirone efficacy.
    • Analysis of in vitro studies on benzodiazepine receptor binding.

    Related Experiment Videos

  • Examination of behavioral testing results for buspirone's effects.
  • Neuropharmacological studies investigating dopamine's role in animal anxiety models.

    • Main Results:

    • Buspirone demonstrates anxiolytic efficacy without interacting with the benzodiazepine/GABA axis.
    • Buspirone exhibits both dopamine agonist and antagonist properties.
    • Behavioral studies show buspirone lacks sedative, muscle relaxant, and dependence-forming effects.
    • Dopamine system interaction is proposed as the mechanism for buspirone's anxiolytic action.

    Conclusions:

    • Buspirone's anxioselectivity stems from its interaction with the dopaminergic system, not the GABAergic system.
    • Dopamine is implicated in the etiology and expression of anxiety.
    • Dopaminergic agents hold potential for anxiety pharmacotherapy, warranting further investigation.